TY - JOUR
T1 - Impact of adherence to antidepressants on long-term prescription opioid use cessation
AU - Scherrer, Jeffrey F.
AU - Salas, Joanne
AU - Sullivan, Mark D.
AU - Ahmedani, Brian K.
AU - Copeland, Laurel A.
AU - Bucholz, Kathleen K.
AU - Burroughs, Thomas
AU - Schneider, F. David
AU - Lustman, Patrick J.
N1 - Publisher Copyright:
© The Royal College of Psychiatrists 2018.
PY - 2018/2
Y1 - 2018/2
N2 - Background Depression contributes to persistent opioid analgesic use (OAU). Treating depression may increase opioid cessation. Aims To determine if adherence to antidepressant medications (ADMs) v. non-adherence was associated with opioid cessation in patients with a new depression episode after >90 days of OAU. Method Patients with non-cancer, non-HIV pain (n = 2821), with a new episode of depression following >90 days of OAU, were eligible if they received =1 ADM prescription from 2002 to 2012. ADM adherence was defined as >80% of days covered. Opioid cessation was defined as =182 days without a prescription refill. Confounding was controlled by inverse probability of treatment weighting. Results In weighted data, the incidence rate of opioid cessation was significantly (P = 0.007) greater in patients who adhered v. did not adhered to taking antidepressants (57.2/1000 v. 45.0/1000 person-years). ADM adherence was significantly associated with opioid cessation (odds ratio (OR) = 1.24, 95% CI 1.05-1.46). Conclusions ADM adherence, compared with non-adherence, is associated with opioid cessation in non-cancer pain. Opioid taper and cessation may be more successful when depression is treated to remission.
AB - Background Depression contributes to persistent opioid analgesic use (OAU). Treating depression may increase opioid cessation. Aims To determine if adherence to antidepressant medications (ADMs) v. non-adherence was associated with opioid cessation in patients with a new depression episode after >90 days of OAU. Method Patients with non-cancer, non-HIV pain (n = 2821), with a new episode of depression following >90 days of OAU, were eligible if they received =1 ADM prescription from 2002 to 2012. ADM adherence was defined as >80% of days covered. Opioid cessation was defined as =182 days without a prescription refill. Confounding was controlled by inverse probability of treatment weighting. Results In weighted data, the incidence rate of opioid cessation was significantly (P = 0.007) greater in patients who adhered v. did not adhered to taking antidepressants (57.2/1000 v. 45.0/1000 person-years). ADM adherence was significantly associated with opioid cessation (odds ratio (OR) = 1.24, 95% CI 1.05-1.46). Conclusions ADM adherence, compared with non-adherence, is associated with opioid cessation in non-cancer pain. Opioid taper and cessation may be more successful when depression is treated to remission.
UR - http://www.scopus.com/inward/record.url?scp=85043532104&partnerID=8YFLogxK
U2 - 10.1192/bjp.2017.25
DO - 10.1192/bjp.2017.25
M3 - Article
C2 - 29436331
AN - SCOPUS:85043532104
SN - 0007-1250
VL - 212
SP - 103
EP - 111
JO - British Journal of Psychiatry
JF - British Journal of Psychiatry
IS - 2
ER -